Data-driven precision medicine

DNAlytics develops innovative data-driven precision medicine solutions (diagnosis, prognosis, treatment guidance) through partnerships with healthcare players such as pharmaceutical, biotechnological or In Vitro Diagnostic (IVD) companies. DNAlytics wants its solutions to have a major impact on patients, healthcare practitioners and Society as a whole.

DNAlytics is a Belgian company founded in 2012 as a UCLouvain Spin-Off that bases its activities on a data mining technology platform. Aside from product (co)development, DNAlytics also proposes its expertise in the form of a data mining consultancy service. In this context we serve various types of customers.

DNAlytics received various awards, namely from IBM, Microsoft, the European Commission or the MIT, both for its technology and its business model.

Stay connected with us! Subscribe to our newsletter. We won’t spam you, we’ll just share good news about DNAlytics from time to time.

Rheumatology: RheumaKit

RheumaKit is a set of tools for the management of patients with arthritis, enabling differential diagnosis with RheumaKit-Dx, patient monitoring and clinical studies management with RheumaKit-Timeline (for rheumatologist) and RheumaKit for Patients (mobile application), as well as treatment response prediction / theranosis with RheumaKit-Tx. For further information on RheumaKit, click here H2020 SME Instrument…

Oncology: ColonoKit

Press release, 24 March 2017 : VIB and DNAlytics team up to develop the ColonoKit, a non-invasive Colorectal Cancer screening test. Download the press release: English Dutch French Subsequently to this press release, we at DNAlytics and our colleagues at VIB and KULeuven received many inquiries from patients willing to benefit from the test.…

Services

A tailored, on-demand data mining consultancy service for pharmaceutical, biotechnology and IVD companies, as well as academic research laboratories. We build diagnostic, prognostic, theranostic solutions based on mathematical modeling.